SKINVISIBLE INC Files SEC form 10-Q, Quarterly Report

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believes," "project," "expects," "anticipates," "estimates," "intends," "strategy," "plan," "may," "will," "would," "will be," "will continue," "will likely result," and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse affect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue rel...
Click here to read the whole Article (external link)

Skinvisible Signs License Agreement for DermSafe to Fight H1N1

LAS VEGAS, Sept. 24, 2009 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI - News), a pharmaceutical research and development company, announced today that it has entered into an exclusive license agreement with Mayquest Pharmaceuticals Pte. Ltd. for the rights for DermSafe(R), Skinvisible's patented antimicrobial hand sanitizer lotion proven to kill the H1N1 swine flu virus. The license agreement includes Singapore, Malaysia, Thailand, Indonesia and the Philippines. Under the terms of the agreement, Mayquest will pay an upfront license fee in milestones for the exclusive manufacturing and marketing rights for DermSafe in the territory. Skinvisible will also receive on-going royalties from product sales. "Mayquest is an excellent partner to bring DermSafe to both the retail and healthcare market in Southeast Asia," said Mr. Terry Howlett, President and CEO of Skinvisible. "This agreement represents an important step in accelerating our worldwide approval and commercialization of DermSafe for the prevention of the spread of the swine flu and other viruses and bacteria. Mayquest has strong medical and regulatory contacts along with the financial backing required to bring DermSafe quickly and successfully to market." He added, "This is our first licensing agreement for DermSafe and we continue to actively seek and negotiate license agreements for other countries worldwide." According to the World Health Organization, the H1N1 is already present in more than 170 countries and territories in t...
Click here to read the whole Article (external link)

SKINVISIBLE INC Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

SKINVISIBLE INC Files SEC form 10-Q, Quarterly Report

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believes," "project," "expects," "anticipates," "estimates," "intends," "strategy," "plan," "may," "will," "would," "will be," "will continue," "will likely result," and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse affect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue rel...
Click here to read the whole Article (external link)

SKINVISIBLE INC Files SEC form 8-K, Other Events

Show all filings for SKINVISIBLE INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for SKINVISIBLE INC 31-Jul-2009Other Events Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes...
Click here to read the whole Article (external link)

Invisicare Approved for Additional U.S. Patent

LAS VEGAS, July 31, 2009 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI - News), a research and development company of topical dermatology products, announced today that it has been approved for a new United States patent for its polymer technology Invisicare. The allowed patent covers additional components of the company's unique technology that enhances topically applied skincare products. In addition to the current patents granted in the United States for Invisicare, this patent adds protection in new areas, covering eight new claims. The Invisicare patent covers the distinct areas of: Methods of Manufacturing, Composition and Methods of Use. With this new patent Skinvisible is allowed additional protection for its Invisicare technology under the category of Topical Composition and Topical Composition Precursor. The United States patent office has also extended the life of this patent a further one and a half years. "This announcement strengthens Skinvisible's intellectual property protection for our proprietary formulated dermatology and consumer goods products that we have developed using Invisicare," said Mr. Terry Howlett, President and CEO of Skinvisible. "We believe this added IP strength will be one of the catalysts to further our licensing efforts not only in the United States but also around the world." He added, "We are also confident that this fortified technology patent, the backbone to our DermSafe(r) hand sanitizer proven effective against the H1N1 swine flu virus, will allow us to make further in...
Click here to read the whole Article (external link)

SKINVISIBLE INC Files SEC form 8-K, Regulation FD Disclosure

Show all filings for SKINVISIBLE INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for SKINVISIBLE INC 20-Jul-2009Regulation FD Disclosure Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trad...
Click here to read the whole Article (external link)

Skinvisible Prepares as H1N1 (Swine Flu) Virus Spreads

LAS VEGAS, July 17, 2009 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI - News), a research and development company of patented skincare and medical dermatology products, previously announced that DermSafe, the Company's hand sanitizing lotion, has been proven effective in killing the H1N1 virus. The studies were conducted by Retroscreen Virology of London, England U.K. demonstrating a greater than 99.99% inactivation/kill on the H1N1 influenza A virus. The spread of this virus and the declaration of a pandemic by the World Health Organization (WHO) has increased Skinvisible's efforts in the global licensing of DermSafe. On June 11, 2009, WHO raised their pandemic threat to a Phase 6 -- "the virus is contagious, spreading easily from one person to another and from one country to another." On the same date over 30,000 cases were confirmed in 74 countries. Less than one month later, the confirmed cases tripled in number to over 94,000, and the number continues to grow. In the United States, the CDC estimates that over one million Americans currently have the flu virus, while Canadian health officials estimated that over 30% of Canadians or 10 million people will come down with this virus in the coming flu season. The British health minister stated that by the end of August, Britain could experience 100,000 new cases each day. In the southern hemisphere, where it is now winter, Argentina's health minister reports that the number of deaths due to the H1N1 influenza A virus had reached 137, with a total of 3,05...
Click here to read the whole Article (external link)

Skinvisible Receives Comprehensive Patent in China

LAS VEGAS, June 25, 2009 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI - News; Website: www.skinvisible.com), is pleased to announce that it has been granted a comprehensive patent in China for Invisicare; Skinvisible's polymer delivery system that enhances topically delivered products. This patent covers the areas of 'Topical Composition', 'Topical Composition Precursor', and 'Methods for Manufacturing and Using'. This patent in China will assist Skinvisible in solidifying on-going negotiations with potential licensees and to continue to expand its offerings into Asia. Receiving a patent that contains all three key components, gives potential licensees the protection needed to begin marketing products in China. Skinvisible continues to make advances in China with potential licensees for its products; most notably with its DermSafe(r) hand sanitizer made without alcohol and proven to kill/inactivate the H1N1 virus. "Receiving this patent in China gives Skinvisible a great advantage in the Asian marketplace," said Mr. Terry Howlett, President and CEO of Skinvisible. "We know how important patent protection is for our potential licensees, so we continue to gain advantages as more of our patents are granted. Patent protection increases the value of Skinvisible formulations and allows licensees the securit...
Click here to read the whole Article (external link)